Come up with a name for your new list and we'll add to it:
Cureveda raised a round of funding on September 16, 2015. Investors include
Maryland Technology Development Corporation.
Cureveda is focused on the discovery, development and commercialization of novel small molecule drugs for the treatment of inflammatory, autoimmune and neurological diseases.…